Machekano R, McFarland W, Mbizvo M T, Bassett M T, Katzenstein D, Latif A S
Zimbabwe Aids Prevention Project, University of Zimbabwe Medical School, Harare, Zimbabwe.
Cent Afr J Med. 1998 Apr;44(4):98-102.
To assess the impact of HIV counselling and testing on HIV seroconversion and incidence of reported sexually transmitted diseases (STDs) among male factory workers in Harare, Zimbabwe.
Prospective, observational study among men recruited to participate in a future workplace based AIDS prevention intervention.
Participants provided STD histories and blood for HIV antibody testing at enrolment and six month intervals during visits to factories. Participants received HIV test results, post test counselling, and free STD services at the project clinic.
Between March 1993 and June 1995, 2,414 men were enrolled with 85% follow up. Overall HIV sero-incidence was 2.60 per 100 person-years; the incidence of reported STDs was 10.19 per 100 person-years. Men who obtained their HIV test results had significantly higher HIV sero-incidence and incidence of reported STDs compared to men who did not obtain their results (IRRs: 1.87, 3.47, respectively). Among men who obtained their HIV test results, a non-significant 40% decrease in HIV sero-incidence was observed after obtaining test results compared to before obtaining results (p = 0.18). The incidence of reported STDs, however, increased by 30% after obtaining HIV test results (p = 0.10).
Decreased HIV sero-incidence in the face of increased reported STD incidence suggests that timely treatment of STDs may decrease the risk of acquiring HIV even in the absence of behaviour change. In populations with high rates of HIV and STDs, the greatest benefit of HIV counselling and testing may be achieved by simultaneously offering STD screening and treatment services.
评估津巴布韦哈拉雷男性工厂工人中,艾滋病咨询与检测对艾滋病毒血清转化及报告的性传播疾病(STD)发病率的影响。
对招募参与未来基于工作场所的艾滋病预防干预措施的男性进行前瞻性观察研究。
参与者在入组时以及每次到工厂就诊期间,每六个月提供性传播疾病病史并进行艾滋病毒抗体检测。参与者在项目诊所接受艾滋病毒检测结果、检测后咨询以及免费的性传播疾病服务。
1993年3月至1995年6月期间,共招募了2414名男性,随访率为85%。总体艾滋病毒血清发病率为每100人年2.60例;报告的性传播疾病发病率为每100人年10.19例。与未获得艾滋病毒检测结果的男性相比,获得检测结果的男性艾滋病毒血清发病率和报告的性传播疾病发病率显著更高(发病率比值分别为1.87和3.47)。在获得艾滋病毒检测结果的男性中,与获得结果前相比,获得结果后艾滋病毒血清发病率有40%的下降,但差异无统计学意义(p = 0.18)。然而,获得艾滋病毒检测结果后,报告的性传播疾病发病率增加了30%(p = 0.10)。
在报告的性传播疾病发病率增加的情况下,艾滋病毒血清发病率下降表明,即使在没有行为改变的情况下,及时治疗性传播疾病可能会降低感染艾滋病毒的风险。在艾滋病毒和性传播疾病高发人群中,通过同时提供性传播疾病筛查和治疗服务,可能会实现艾滋病咨询与检测的最大益处。